Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Alzheimer's Disease

Free Subscription Articles published in Am J Geriatr Psychiatry Retrieve available abstracts of 63 articles: HTML format

Single Articles

April 2026
1. GUERRERA CS, Platania GA, Varrasi S, Sarti P, et al
   Investigating the Multidimensional Structure of Apathy in Cognitive Decline: An Exploratory Network Analysis of the Apathy Evaluation Scale.
   Am J Geriatr Psychiatry. 2026;34:450-461.
   PubMed     Abstract available
   
   
   March 2026
2. AW TBH, Leow YJ, Kandiah N
   Association of Plasma p-tau181 and Cognition in Nondemented Subjects Without Abeta(42/40) Positivity.
   Am J Geriatr Psychiatry. 2026;34:386-391.
   PubMed     Abstract available
   
   
   February 2026
3. RHODES E, Insel PS, Kassel M, Kryza-Lacombe M, et al
   Accelerated Cognitive Decline in Late Life Depression: The Role of Amyloid-beta, Cortico-Limbic Volume, and White Matter Hyperintensities.
   Am J Geriatr Psychiatry. 2026;34:183-194.
   PubMed     Abstract available
   
   
   
4. FRIES GR, De La Garza S, Zhao NO, Bass AW, et al
   Preliminary Investigation of the Association Between Epigenetic Aging Acceleration and Amyloid Biomarkers in Bipolar Disorder.
   Am J Geriatr Psychiatry. 2026;34:210-221.
   PubMed     Abstract available
   
   
   January 2026
5. SU X, Wang Y, Zhao B, Wang C, et al
   Resting-State Cerebral Blood Flow and Its Disconnect From Functional Connectivity in Alzheimer's Disease Spectrum.
   Am J Geriatr Psychiatry. 2026 Jan 31:S1064-7481(26)00038.
   PubMed     Abstract available
   
   
   
6. ZIDE BS, Gagliardi G, Jacobs HIL, Gatchel JR, et al
   Living Alone, Early Tau Pathology, and Loneliness in Cognitively Unimpaired Older Adults During the COVID-19 Pandemic.
   Am J Geriatr Psychiatry. 2026;34:57-69.
   PubMed     Abstract available
   
   
   December 2025
7. SAH SS, Kumbhalwar A
   Comment on "Housing Assistance and Health Care Access Among Older Adults With Alzheimer's Disease and Related Dementias: Evidence From Multisource Linked Survey-Administrative Data".
   Am J Geriatr Psychiatry. 2025 Dec 12:S1064-7481(25)00560.
   PubMed    
   
   
   
8. CHERUBINI V, Prata O, Fattobene L, Ceravolo MG, et al
   Profiles of Vulnerability to Financial Exploitation in the Degenerative Dementias.
   Am J Geriatr Psychiatry. 2025;33:1290-1300.
   PubMed     Abstract available
   
   
   November 2025
9. SAHA S, Spalzang S, Padhy SK, Parmar A, et al
   Reflections on a Study of Low-Dose Agomelatine as Add-on for Agitation in Alzheimer's Disease.
   Am J Geriatr Psychiatry. 2025 Nov 22:S1064-7481(25)00531.
   PubMed    
   
   
   
10. TAMPI RR
    Dronabinol for Agitation in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2025 Nov 17:S1064-7481(25)00526.
    PubMed    
    
    
    
11. ROSENBERG PB, Amjad H, Burhanullah H, Nowrangi M, et al
    A Randomized Controlled Trial of the Safety and Efficacy of Dronabinol for Agitation in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2025 Nov 10:S1064-7481(25)00506.
    PubMed     Abstract available
    
    
    
12. FENELON A, Chen J
    Housing Assistance and Health Care Access Among Older Adults with Alzheimer's Disease and Related Dementias: Evidence from Multisource Linked Survey-Administrative Data.
    Am J Geriatr Psychiatry. 2025 Nov 9:S1064-7481(25)00527.
    PubMed     Abstract available
    
    
    
13. NGUYEN HT, Nguyen BT, Nguyen PQ, Nguyen BH, et al
    A Screening Protocol to Identify Older Adults With Dementia and Their Family Caregivers in Northern Vietnam.
    Am J Geriatr Psychiatry. 2025;33:1134-1144.
    PubMed     Abstract available
    
    
    October 2025
14. PEREIRA DA SILVA AM, de Deus O, Ribeiro FV, Tudella GCN, et al
    Efficacy and Safety of Lithium for Behavioral and Cognitive Symptoms in Alzheimer's Disease Dementia: A Systematic Review With Frequentist and Bayesian Meta-Analysis.
    Am J Geriatr Psychiatry. 2025 Oct 4:S1064-7481(25)00496.
    PubMed     Abstract available
    
    
    September 2025
15. JENKINS LM, Heywood AA, Gurvich C
    Beyond Alzheimer's Pathology: Contributions to Cognitive Decline in Late Life Depression.
    Am J Geriatr Psychiatry. 2025 Sep 30:S1064-7481(25)00489.
    PubMed    
    
    
    July 2025
16. TALMASOV D, Johnson AS, Brown PJ, Provenzano FA, et al
    Depressive Symptoms Correlate With Tau Accumulation Rates in Amyloid Positive Adults.
    Am J Geriatr Psychiatry. 2025;33:756-769.
    PubMed     Abstract available
    
    
    June 2025
17. GILDENGERS A, Weinstein AM, Gujral S, Zeng X, et al
    Corrigendum to "Where do plasma biomarkers fit in with current Alzheimer's disease detection?" [volume 33, issue 4, April 2025, pages 428-437].
    Am J Geriatr Psychiatry. 2025 Jun 27:S1064-7481(25)00395.
    PubMed    
    
    
    
18. AMANO T, Inoue M, Dixit S, Tarafder A, et al
    Ethnoracial Disparities in Advance Care Planning Among People With Alzheimer's Disease and Related Dementias.
    Am J Geriatr Psychiatry. 2025 Jun 12:S1064-7481(25)00364.
    PubMed     Abstract available
    
    
    
19. BONAR EE, Tan CY, Patyk A, Lei L, et al
    Agitation in Alzheimer's Disease as a Qualifying Condition for Medical Cannabis in the United States: A Brief Report on Current Trends.
    Am J Geriatr Psychiatry. 2025 Jun 11:S1064-7481(25)00363.
    PubMed     Abstract available
    
    
    May 2025
20. GONZALEZ DA, Finley JA, Patel SES, Soble JR, et al
    Practical Assessment of Neuropsychiatric Symptoms: Updated Reliability, Validity, and Cutoffs for the Neuropsychiatric Inventory Questionnaire.
    Am J Geriatr Psychiatry. 2025;33:524-534.
    PubMed     Abstract available
    
    
    April 2025
21. YANG Y, Kwak YT
    Network Analysis of Delusion Subtypes in Amyloid PET-Positive, Drug-Naive Alzheimer's Disease Patients.
    Am J Geriatr Psychiatry. 2025 Apr 22:S1064-7481(25)00329.
    PubMed     Abstract available
    
    
    March 2025
22. KARGAR A, Fetratjoo DH, Moattar R, Tarki A, et al
    Efficacy of Add-On Agomelatine on Agitation, Aggression, and Neuroprotection in Alzheimer's Disease: A Randomized, Blinded, Controlled Trial.
    Am J Geriatr Psychiatry. 2025 Mar 20:S1064-7481(25)00082.
    PubMed     Abstract available
    
    
    
23. TAN WY, Hargreaves CA, Dawe GS, Hsu W, et al
    Incremental Value of Multidomain Risk Factors for Dementia Prediction: A Machine Learning Approach.
    Am J Geriatr Psychiatry. 2025;33:229-244.
    PubMed     Abstract available
    
    
    February 2025
24. PLYS E, Moss KO, Jacklin K, Yazzie M, et al
    Discontinuing the Term "Stakeholder" From the NIA IMPACT Collaboratory Engaging Partners Team: An Example of the Process of Language Change in an Organization.
    Am J Geriatr Psychiatry. 2025;33:192-199.
    PubMed     Abstract available
    
    
    
25. CHU CS, Cheng SL, Bai YM, Su TP, et al
    Risk of Dementia in Different Types of Cancer Survivors: A Nationwide Cohort Study.
    Am J Geriatr Psychiatry. 2025;33:156-166.
    PubMed     Abstract available
    
    
    January 2025
26. LEE H, Kim BH, Lee EH, Shin D, et al
    Corrigendum to "Brain Metabolic Resiliencein Alzheimer's Disease: A Predictor of Cognitive Decline and Conversion to Dementia [Am J of Geriatric Psychiatry (2024) in press, 1-11].
    Am J Geriatr Psychiatry. 2025 Jan 21:S1064-7481(25)00016.
    PubMed    
    
    
    December 2024
27. LEE H, Kim BH, Lee EH, Shin D, et al
    Brain Metabolic Resilience in Alzheimer's Disease: A Predictor of Cognitive Decline and Conversion to Dementia.
    Am J Geriatr Psychiatry. 2024 Dec 3:S1064-7481(24)00543.
    PubMed     Abstract available
    
    
    
28. CHEN J, Jang S, Wang MQ
    Medicare Payments and ACOs for Dementia Patients Across Race and Social Vulnerability.
    Am J Geriatr Psychiatry. 2024;32:1433-1442.
    PubMed     Abstract available
    
    
    November 2024
29. MOREHOUSE CR, Hendriks S, Rabbee N, Kim SY, et al
    Do Caregivers Value the New Antiamyloid Treatments for Alzheimer's Disease More Than Home-Based Care?
    Am J Geriatr Psychiatry. 2024 Nov 26:S1064-7481(24)00541.
    PubMed     Abstract available
    
    
    
30. AGA VM
    Brexpiprazole for the Treatment of Agitation in Alzheimer's Disease Dementia: Clinical Uncertainties and the Path Forward.
    Am J Geriatr Psychiatry. 2024 Nov 19:S1064-7481(24)00533.
    PubMed     Abstract available
    
    
    October 2024
31. ALSHIBAN A, Hasoglu T, Oster J
    Efficacy And Safety of Dual Orexin Receptor Antagonist (DORA) For Sleep Disturbance in Patients With Alzheimer's Disease Dementia. A Review Article.
    Am J Geriatr Psychiatry. 2024 Oct 3:S1064-7481(24)00480.
    PubMed     Abstract available
    
    
    
32. LEE S, Zide BS, Palm ST, Drew WJ, et al
    Specific Association of Worry With Amyloid-beta But Not Tau in Cognitively Unimpaired Older Adults.
    Am J Geriatr Psychiatry. 2024;32:1203-1214.
    PubMed     Abstract available
    
    
    
33. GILDENGERS A, Weinstein AM, Gujral S, Zeng X, et al
    Where Do Plasma Biomarkers fit in With Current Alzheimer's Disease Detection?
    Am J Geriatr Psychiatry. 2024 Oct 1:S1064-7481(24)00478.
    PubMed     Abstract available
    
    
    August 2024
34. KHASNAVIS S, O'Dell RS, van Dyck CH, Mecca AP, et al
    Commentary on "Study Partner Report of Apathy in Older Adults is Associated With AD Biomarkers: Findings From the Harvard Aging Brain Study".
    Am J Geriatr Psychiatry. 2024;32:920-921.
    PubMed    
    
    
    
35. BURLING JE, Katz Z, Yuan Z, Munro C, et al
    Study Partner Report of Apathy in Older Adults is Associated with AD Biomarkers: Findings from the Harvard Aging Brain Study.
    Am J Geriatr Psychiatry. 2024;32:909-919.
    PubMed     Abstract available
    
    
    July 2024
36. VANDE CASTEELE T, Laroy M, Van Cauwenberge M, Vanderlinden G, et al
    Late Life Depression is Not Associated With Alzheimer-Type Tau: Preliminary Evidence From a Next-Generation Tau Ligand PET-MR Study.
    Am J Geriatr Psychiatry. 2024 Jul 18:S1064-7481(24)00401.
    PubMed     Abstract available
    
    
    
37. LANCTOT KL
    Commentary on Neuropsychiatric Symptom Profile in Alzheimer's Disease and their Relationship with Functional Decline.
    Am J Geriatr Psychiatry. 2024 Jul 16:S1064-7481(24)00400.
    PubMed    
    
    
    
38. VAN DEN BULCKE L, Davidoff H, Heremans E, Potts Y, et al
    Acoustic Stimulation to Improve Slow-Wave Sleep in Alzheimer's Disease: A Multiple Night At-Home Intervention.
    Am J Geriatr Psychiatry. 2024 Jul 8:S1064-7481(24)00384.
    PubMed     Abstract available
    
    
    
39. ZANDBAGLEH A, Miltiadous A, Sanei S, Azami H, et al
    Beta-to-Theta Entropy Ratio of EEG in Aging, Frontotemporal Dementia, and Alzheimer's Dementia.
    Am J Geriatr Psychiatry. 2024 Jul 4:S1064-7481(24)00380.
    PubMed     Abstract available
    
    
    June 2024
40. ZHU CW, Schneider LS, Elder GA, Soleimani L, et al
    Neuropsychiatric Symptom Profile in Alzheimer's Disease and Their Relationship With Functional Decline.
    Am J Geriatr Psychiatry. 2024 Jun 29:S1064-7481(24)00375.
    PubMed     Abstract available
    
    
    
41. SHAW JS, Leoutsakos JM, Rosenberg PB
    The Relationship Between First Presenting Neuropsychiatric Symptoms in Older Adults and Autopsy-Confirmed Memory Disorders.
    Am J Geriatr Psychiatry. 2024;32:754-764.
    PubMed     Abstract available
    
    
    
42. GALLET Q, Bouteloup V, Locatelli M, Habert MO, et al
    Cerebral Metabolic Signature of Chronic Benzodiazepine Use in Nondemented Older Adults: An FDG-PET Study in the MEMENTO Cohort.
    Am J Geriatr Psychiatry. 2024;32:665-677.
    PubMed     Abstract available
    
    
    March 2024
43. JANG S, Chen J
    National Estimates of Incremental Work Absenteeism Costs Associated With Adult Children of Parents With Alzheimer's Disease and Related Dementias.
    Am J Geriatr Psychiatry. 2024 Mar 28:S1064-7481(24)00294.
    PubMed     Abstract available
    
    
    
44. TWAIT EL, Kamarioti M, Verberk IMW, Teunissen CE, et al
    Depressive Symptoms and Plasma Markers of Alzheimer's Disease and Neurodegeneration: A Coordinated Meta-Analysis of 8 Cohort Studies.
    Am J Geriatr Psychiatry. 2024 Mar 11:S1064-7481(24)00274.
    PubMed     Abstract available
    
    
    
45. SISTI A, Gutman R, Mor V, Dionne L, et al
    Using Structured Observations to Evaluate the Effects of a Personalized Music Intervention on Agitated Behaviors and Mood in Nursing Home Residents With Dementia: Results From an Embedded, Pragmatic Randomized Controlled Trial.
    Am J Geriatr Psychiatry. 2024;32:300-311.
    PubMed     Abstract available
    
    
    January 2024
46. DINIZ BS
    Immunotherapy in Alzheimer's Disease: From the Bench to the Bedside.
    Am J Geriatr Psychiatry. 2024 Jan 14:S1064-7481(24)00013.
    PubMed    
    
    
    December 2023
47. ZHAI Z, Kong F, Zhu Z, Dai J, et al
    Effect and Potential Mechanism of Immunotherapy on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Am J Geriatr Psychiatry. 2023 Dec 7:S1064-7481(23)00491.
    PubMed     Abstract available
    
    
    
48. KERCKHOVE N, Bornier N, Mulliez A, Elyn A, et al
    Prevalence of Chronic Pain Among People with Dementia: A Nationwide Study Using French Administrative Data.
    Am J Geriatr Psychiatry. 2023;31:1149-1163.
    PubMed     Abstract available
    
    
    
49. LANCTOT KL, Rivet L, Tumati S, Perin J, et al
    Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial.
    Am J Geriatr Psychiatry. 2023;31:1077-1087.
    PubMed     Abstract available
    
    
    October 2023
50. FENG V, Lanctot K, Herrmann N, Kiss A, et al
    Lipopolysaccharide, Immune Biomarkers and Cerebral Amyloid-Beta Deposition in Older Adults With Mild Cognitive Impairment & Major Depressive Disorder.
    Am J Geriatr Psychiatry. 2023;31:786-795.
    PubMed     Abstract available
    
    
    September 2023
51. FU JF
    Assessment of Gray Matter Microstructure and Synaptic Density in Alzheimer's Disease: A Multimodal Imaging Study With DTI and SV2A PET: A Commentary on Silva-Rudberg et al.
    Am J Geriatr Psychiatry. 2023 Sep 14:S1064-7481(23)00408.
    PubMed    
    
    
    August 2023
52. JOE E, Segal-Gidan F, Cummings JL, Galasko D, et al
    Association Between Self- and Proxy-Reported Depression and Quality of Life in Mild-Moderate Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2023 Aug 24:S1064-7481(23)00389.
    PubMed     Abstract available
    
    
    
53. GRILL JD
    Remaining Questions in a Brave New World of Alzheimer's Disease Care.
    Am J Geriatr Psychiatry. 2023 Aug 19:S1064-7481(23)00391.
    PubMed    
    
    
    
54. KIM JE, Tamres LK, Orbell SL, Cheng RZ, et al
    "And Does That Necessarily Mean Absolutely Alzheimer's?" An Analysis of Questions Raised Following Amyloid PET Results Disclosure.
    Am J Geriatr Psychiatry. 2023 Aug 13:S1064-7481(23)00388.
    PubMed     Abstract available
    
    
    
55. SILVA-RUDBERG JA, Salardini E, O'Dell RS, Chen MK, et al
    Assessment of Gray Matter Microstructure and Synaptic Density in Alzheimer's Disease: A Multimodal Imaging Study With DTI and SV2A PET.
    Am J Geriatr Psychiatry. 2023 Aug 11:S1064-7481(23)00386.
    PubMed     Abstract available
    
    
    
56. HINKLE JT, Pontone GM
    Invited Perspective on "BPSD Patterns in Patients With Severe Neuropsychiatric Disturbances: Insight From the RECAGE Study" (Cognat et al. 2023): Roles for nosology and neurobiology in understanding the heterogeneity of BPSD.
    Am J Geriatr Psychiatry. 2023;31:640-642.
    PubMed    
    
    
    
57. COGNAT E, Sabia S, Fayel A, Lilamand M, et al
    BPSD Patterns in Patients With Severe Neuropsychiatric Disturbances: Insight From the RECAGE Study.
    Am J Geriatr Psychiatry. 2023;31:633-639.
    PubMed     Abstract available
    
    
    
58. GINTERS M, Talaslahti T, Palm A, Kautiainen H, et al
    Criminal Behaviour After Diagnosis of a Neurocognitive Disorder: A Nationwide Finnish Register Study.
    Am J Geriatr Psychiatry. 2023;31:598-606.
    PubMed     Abstract available
    
    
    July 2023
59. BABULAL GM, Chen L, Murphy SA, Doherty JM, et al
    Neuropsychiatric Symptoms and Alzheimer Disease Biomarkers Independently Predict Progression to Incident Cognitive Impairment.
    Am J Geriatr Psychiatry. 2023 Jul 26:S1064-7481(23)00368.
    PubMed     Abstract available
    
    
    
60. LAMAR M, Arfanakis K, Yu L, Kapasi A, et al
    The Relationship of MRI-Derived Alzheimer's and Cerebrovascular-Related Signatures With Level of and Change in Health and Financial Literacy.
    Am J Geriatr Psychiatry. 2023 Jul 22:S1064-7481(23)00367.
    PubMed     Abstract available
    
    
    
61. ASHFORD JW
    Neuroplasticity: The Critical Issue for Alzheimer's Disease and Links to Obesity and Depression.
    Am J Geriatr Psychiatry. 2023 Jul 15:S1064-7481(23)00354.
    PubMed    
    
    
    June 2023
62. LY M, Yu GZ, Mian A, Cramer A, et al
    Neuroinflammation: A Modifiable Pathway Linking Obesity, Alzheimer's disease, and Depression.
    Am J Geriatr Psychiatry. 2023 Jun 11:S1064-7481(23)00318.
    PubMed     Abstract available
    
    
    February 2023
63. KUNICKI ZJ, Frietchen R, McGeary JE, Jiang L, et al
    Prevalence of Comorbid Depression and Insomnia Among Veterans Hospitalized for Heart Failure with Alzheimer Disease and Related Disorders.
    Am J Geriatr Psychiatry. 2023 Feb 8:S1064-7481(23)00163.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum